%PDF-1.5
%
1 0 obj
<<
/Lang (en)
/MarkInfo <<
/Marked true
>>
/Metadata 2 0 R
/Outlines 3 0 R
/PageLayout /OneColumn
/PageMode /UseOutlines
/Pages 4 0 R
/StructTreeRoot 5 0 R
/Type /Catalog
/ViewerPreferences <<
/DisplayDocTitle true
>>
>>
endobj
6 0 obj
<<
/Author (Gemeinsamer Bundesausschuss/ Federal Joint Committee \(g-ba.de\))
/Category ()
/Comments ()
/Company ()
/CreationDate (D:20210812123309+02'00')
/Creator <4163726F626174205044464D616B65722031352066FC7220576F7264>
/Keywords <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>
/ModDate (D:20210812123519+02'00')
/Producer (Adobe PDF Library 15.0)
/SourceModified (D:20210812101134)
/Subject (Pharmaceuticals Directive \(AM-L\))
/Title (Resolution)
>>
endobj
2 0 obj
<<
/Length 4920
/Subtype /XML
/Type /Metadata
>>
stream
2021-08-12T12:35:19+02:00
2021-08-12T12:33:09+02:00
2021-08-12T12:35:19+02:00
Acrobat PDFMaker 15 für Word
uuid:55272f84-4e42-4c62-b928-6f09e6f03b71
uuid:605e8f2e-03af-4618-a05f-ae85d9b6a13e
1
application/pdf
Resolution
Pharmaceuticals Directive (AM-L)
Gemeinsamer Bundesausschuss/ Federal Joint Committee (g-ba.de)
Annex XII - Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V:
Pertuzumab/trastuzumab (breast cancer
HER2-positive
locally advanced
inflammatory
or early stage breast cancer at high risk of recurrence
neoadjuvant)
Adobe PDF Library 15.0
Annex XII - Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V:
Pertuzumab/trastuzumab (breast cancer, HER2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrence, neoadjuvant)
D:20210812101134
endstream
endobj
3 0 obj
<<
/Count 7
/First 7 0 R
/Last 8 0 R
/Type /Outlines
>>
endobj
4 0 obj
<<
/Count 7
/Kids [9 0 R 10 0 R 11 0 R 12 0 R 13 0 R 14 0 R 15 0 R]
/Type /Pages
>>
endobj
5 0 obj
<<
/K 16 0 R
/ParentTree 17 0 R
/ParentTreeNextKey 12
/RoleMap 18 0 R
/Type /StructTreeRoot
>>
endobj
7 0 obj
<<
/A 19 0 R
/Count 1
/First 20 0 R
/Last 20 0 R
/Next 8 0 R
/Parent 3 0 R
/Title (Resolution)
>>
endobj
8 0 obj
<<
/A 21 0 R
/Count 4
/First 22 0 R
/Last 23 0 R
/Parent 3 0 R
/Prev 7 0 R
/Title (I. In Annex XII, the following information shall be added after No. 4 to the information on the benefit assessment of pertuzumab/trastuzumab in accordance with the resolution of 15 July 2021:)
>>
endobj
9 0 obj
<<
/Contents [24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 33 0 R]
/CS1 [/ICCBased 34 0 R]
>>
/Font <<
/TT0 35 0 R
/TT1 36 0 R
/TT2 37 0 R
>>
/XObject <<
/OL1 38 0 R
>>
>>
/Rotate 0
/StructParents 0
/Tabs /S
/Type /Page
>>
endobj
10 0 obj
<<
/Annots [39 0 R]
/Contents [40 0 R 41 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 33 0 R]
>>
/Font <<
/TT0 35 0 R
/TT1 36 0 R
/TT2 37 0 R
/TT3 42 0 R
>>
/XObject <<
/OL1 38 0 R
>>
>>
/Rotate 0
/StructParents 1
/Tabs /S
/Type /Page
>>
endobj
11 0 obj
<<
/Contents [43 0 R 44 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 33 0 R]
>>
/Font <<
/C2_0 45 0 R
/C2_1 46 0 R
/TT0 35 0 R
/TT1 36 0 R
>>
/XObject <<
/OL1 38 0 R
>>
>>
/Rotate 0
/StructParents 2
/Tabs /S
/Type /Page
>>
endobj
12 0 obj
<<
/Contents [47 0 R 48 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 33 0 R]
>>
/Font <<
/TT0 35 0 R
/TT1 36 0 R
/TT2 42 0 R
>>
/XObject <<
/OL1 38 0 R
>>
>>
/Rotate 0
/StructParents 3
/Tabs /S
/Type /Page
>>
endobj
13 0 obj
<<
/Annots [49 0 R 50 0 R]
/Contents [51 0 R 52 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 33 0 R]
/CS1 [/ICCBased 34 0 R]
>>
/Font <<
/TT0 35 0 R
/TT1 36 0 R
/TT2 37 0 R
>>
/XObject <<
/OL1 38 0 R
>>
>>
/Rotate 0
/StructParents 4
/Tabs /S
/Type /Page
>>
endobj
14 0 obj
<<
/Contents [53 0 R 54 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 33 0 R]
>>
/Font <<
/TT0 35 0 R
/TT1 42 0 R
/TT2 36 0 R
>>
/XObject <<
/OL1 38 0 R
>>
>>
/Rotate 0
/StructParents 7
/Tabs /S
/Type /Page
>>
endobj
15 0 obj
<<
/Annots [55 0 R 56 0 R]
/Contents [57 0 R 58 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 33 0 R]
/CS1 [/ICCBased 34 0 R]
>>
/Font <<
/TT0 35 0 R
/TT1 36 0 R
>>
/XObject <<
/OL1 38 0 R
>>
>>
/Rotate 0
/StructParents 8
/Tabs /S
/Type /Page
>>
endobj
16 0 obj
<<
/K [59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R
69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R
79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R
89 0 R 90 0 R 91 0 R 92 0 R 93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R
99 0 R 100 0 R 101 0 R 102 0 R 103 0 R 104 0 R 105 0 R 106 0 R 107 0 R 108 0 R
109 0 R 110 0 R 111 0 R 112 0 R 113 0 R 114 0 R 115 0 R 116 0 R 117 0 R 118 0 R
119 0 R 120 0 R 121 0 R 122 0 R 123 0 R 124 0 R 125 0 R 126 0 R 127 0 R 128 0 R]
/P 5 0 R
/S /Sect
>>
endobj
17 0 obj
<<
/Nums [0 [59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R]
1 [67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R
77 0 R null 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R null 87 0 R
88 0 R null 129 0 R null 130 0 R 131 0 R 84 0 R 132 0 R]
2 [89 0 R null 133 0 R null 134 0 R null null 135 0 R null 136 0 R
null 137 0 R null null 138 0 R null 139 0 R null 140 0 R null
141 0 R null 142 0 R 143 0 R 144 0 R null 145 0 R null 146 0 R 147 0 R
148 0 R null 149 0 R null 150 0 R 151 0 R 152 0 R null 153 0 R null
154 0 R 155 0 R 156 0 R null 157 0 R null 158 0 R null 159 0 R null
160 0 R null 161 0 R null 162 0 R null 163 0 R null 164 0 R null
165 0 R 91 0 R 92 0 R 93 0 R 94 0 R null 166 0 R null 167 0 R null
null 168 0 R null 169 0 R null null 170 0 R null 171 0 R null
null 172 0 R null 173 0 R null 174 0 R null 175 0 R null 176 0 R
177 0 R 178 0 R 179 0 R 180 0 R 181 0 R 182 0 R 183 0 R 184 0 R 185 0 R 186 0 R
187 0 R 188 0 R null 189 0 R null 190 0 R null 191 0 R null 192 0 R
193 0 R 194 0 R 195 0 R 196 0 R 197 0 R 96 0 R null 198 0 R null 199 0 R
null null 200 0 R null 201 0 R null null 202 0 R null 203 0 R
null null 204 0 R null 205 0 R null 206 0 R null 207 0 R null
208 0 R 209 0 R 210 0 R 211 0 R 212 0 R 213 0 R 214 0 R 215 0 R 216 0 R 217 0 R
218 0 R 219 0 R 220 0 R null 221 0 R null 222 0 R 223 0 R 224 0 R 225 0 R
226 0 R 227 0 R 228 0 R 229 0 R 230 0 R 231 0 R]
3 [null 232 0 R null 233 0 R 234 0 R 235 0 R 236 0 R 237 0 R 238 0 R null
239 0 R null 240 0 R 241 0 R 242 0 R 243 0 R 244 0 R 245 0 R 98 0 R null
246 0 R null 247 0 R null null 248 0 R null 249 0 R null null
250 0 R null 251 0 R null null 252 0 R null 253 0 R null 254 0 R
null 255 0 R null 256 0 R 257 0 R 258 0 R 259 0 R 260 0 R 261 0 R 262 0 R
263 0 R 264 0 R 265 0 R 266 0 R 267 0 R 268 0 R 269 0 R 270 0 R 271 0 R 272 0 R
273 0 R 274 0 R null 275 0 R null 276 0 R 277 0 R 278 0 R 279 0 R 280 0 R
281 0 R 100 0 R null 282 0 R null 283 0 R 102 0 R null 284 0 R null
285 0 R null null 286 0 R null 287 0 R null null 288 0 R null
289 0 R null null 290 0 R null 291 0 R null 292 0 R null 293 0 R
null 294 0 R 295 0 R 296 0 R 297 0 R 298 0 R 299 0 R 300 0 R 301 0 R 302 0 R
303 0 R 304 0 R 305 0 R 306 0 R null 307 0 R null 308 0 R null 309 0 R
null 310 0 R 311 0 R 312 0 R 313 0 R 314 0 R 315 0 R null 316 0 R null
317 0 R null 318 0 R null 319 0 R 320 0 R 321 0 R 322 0 R 323 0 R 324 0 R
null 325 0 R null 326 0 R null 327 0 R null 328 0 R 329 0 R 330 0 R
331 0 R 332 0 R 333 0 R null 334 0 R null 335 0 R null 336 0 R null
337 0 R 338 0 R 339 0 R 340 0 R 341 0 R 342 0 R 343 0 R 344 0 R 345 0 R 346 0 R
347 0 R 348 0 R 349 0 R 350 0 R 351 0 R 352 0 R 342 0 R 353 0 R]
4 [null null null null null null null null null null
null null null null null null null 354 0 R null 355 0 R
104 0 R 105 0 R 106 0 R 107 0 R null null null 109 0 R null 111 0 R
112 0 R 113 0 R null 356 0 R null 357 0 R null null 358 0 R null
359 0 R null 360 0 R null 361 0 R null 362 0 R null 363 0 R null
364 0 R null 365 0 R 366 0 R null 367 0 R null 368 0 R 369 0 R null
370 0 R null 371 0 R 372 0 R null 373 0 R null 374 0 R 375 0 R null
376 0 R null 377 0 R 378 0 R 379 0 R 380 0 R 381 0 R 382 0 R 383 0 R 384 0 R
385 0 R 386 0 R 387 0 R 388 0 R 389 0 R 390 0 R 391 0 R 392 0 R 393 0 R 394 0 R
395 0 R 396 0 R 397 0 R]
5 398 0 R 6 398 0 R 7 [null 399 0 R null 400 0 R null null 401 0 R null 402 0 R null
403 0 R null 404 0 R null 405 0 R 406 0 R null 407 0 R null 408 0 R
409 0 R null 410 0 R null 411 0 R 412 0 R null 413 0 R null 414 0 R
415 0 R null 416 0 R null 417 0 R 418 0 R null 419 0 R null 420 0 R
null 421 0 R 422 0 R 423 0 R null 424 0 R null 425 0 R null 426 0 R
427 0 R 428 0 R null 429 0 R null 430 0 R 431 0 R null 432 0 R null
433 0 R null 434 0 R null 435 0 R null 436 0 R 437 0 R null 438 0 R
null 439 0 R 440 0 R null 441 0 R null 442 0 R 443 0 R null 444 0 R
null 445 0 R 446 0 R null 447 0 R null 448 0 R 449 0 R null 450 0 R
null 451 0 R 452 0 R null 453 0 R null 454 0 R null 455 0 R null
456 0 R 457 0 R null 458 0 R null 459 0 R null 460 0 R 461 0 R 462 0 R
null 463 0 R null 464 0 R 465 0 R null 466 0 R null 467 0 R null
468 0 R 469 0 R 470 0 R null 471 0 R null 472 0 R null 473 0 R 474 0 R
475 0 R null 476 0 R null 477 0 R 478 0 R 115 0 R 116 0 R 117 0 R 118 0 R
119 0 R]
8 [120 0 R null 479 0 R null 480 0 R null 481 0 R null null 482 0 R
null 483 0 R null null 484 0 R null 485 0 R null 486 0 R null
null 487 0 R null 488 0 R null 489 0 R null null 490 0 R null
491 0 R null 492 0 R null 493 0 R null null 494 0 R null 495 0 R
null 496 0 R null 497 0 R null 498 0 R null 499 0 R null 500 0 R
null 501 0 R null 502 0 R null 503 0 R 504 0 R null 505 0 R null
506 0 R 507 0 R 508 0 R 509 0 R 510 0 R 511 0 R null 512 0 R null 513 0 R
514 0 R 515 0 R 516 0 R 517 0 R 518 0 R null 519 0 R null 520 0 R 521 0 R
522 0 R 523 0 R 524 0 R 525 0 R null 526 0 R null 527 0 R 528 0 R 529 0 R
530 0 R 531 0 R 532 0 R null 533 0 R null 534 0 R null 535 0 R null
536 0 R null 537 0 R 538 0 R 539 0 R 540 0 R 541 0 R 542 0 R null 543 0 R
null 544 0 R 545 0 R 546 0 R 547 0 R 548 0 R 549 0 R null 550 0 R null
551 0 R 552 0 R 553 0 R 554 0 R 555 0 R 556 0 R null 557 0 R null 558 0 R
559 0 R 560 0 R 561 0 R 562 0 R 563 0 R null 564 0 R null 565 0 R 566 0 R
567 0 R 568 0 R 569 0 R 570 0 R null 571 0 R null 572 0 R null 573 0 R
122 0 R 123 0 R 124 0 R null null 125 0 R 126 0 R 127 0 R 128 0 R 574 0 R
575 0 R]
9 576 0 R
10 576 0 R 11 131 0 R]
>>
endobj
18 0 obj
<<
/Annotation /Span
/Artifact /P
/Bibliography /BibEntry
/Chart /Figure
/Diagram /Figure
/DropCap /Figure
/Endnote /Note
/Footnote /Note
/GBA_Aufz#C3#A4hlung#201. /P
/GBA_Aufz#C3#A4hlung#20I.II.III /P
/GBA_Datum /P
/GBA_Standard /P
/GBA_Verfasser /P
/Hyperlink /Span
/InlineShape /Figure
/Listenabsatz /P
/Outline /Span
/Standard /P
/Strikeout /Span
/Subscript /Span
/Superscript /Span
/TextBox /Art
/Titel /H1
/Underline /Span
/Untertitel /H2
/markedcontent /Span
/#C3#9Cberschrift#201 /H1
/#C3#9Cberschrift#204 /H4
>>
endobj
19 0 obj
<<
/D [9 0 R /XYZ 69 743 0.0]
/S /GoTo
>>
endobj
20 0 obj
<<
/A 577 0 R
/Parent 7 0 R
/Title (of the Resolution of the Federal Joint Committee \(G-BA\) on an Amendment of the Pharmaceuticals Directive \(AM-L\):)
>>
endobj
21 0 obj
<<
/D [9 0 R /XYZ 69 433 0.0]
/S /GoTo
>>
endobj
22 0 obj
<<
/A 578 0 R
/Next 579 0 R
/Parent 8 0 R
/Title (1. Additional benefit of the medicinal product in relation to the appropriate comparator therapy)
>>
endobj
23 0 obj
<<
/A 580 0 R
/Parent 8 0 R
/Prev 581 0 R
/Title (4. Treatment costs)
>>
endobj
24 0 obj
<<
/Length 37
/Filter /FlateDecode
>>
stream
x+*23P0bdBr.KB W
endstream
endobj
25 0 obj
<<
/Length 805
/Filter /FlateDecode
>>
stream
HVNAWfOr)f$lSvh#`\~\m0;zZ^K:8-jqI2;>I9"wCRt\H=rDs{4~}7_^;Mo9{4v3G31x%4$9ĐK%\i}N"DJj|'[&ט<
)')_B)WtvP\Kک7*Bb 9;[XWk!-Uj؆4lH5H"6hfbW冴+-F_ZZZ{y&Wiܘb風,飂dt*QX:(j!R
T&䬑#{!eC}$l&@$ FlϱS+`'.g6䌹oɉ}!9XA-P-bV;6BPaʻGZ5hsu6' ۮ*X#<CT)BGxM01
zu 4ldE T(sV6K^rj[x
1{G_9Tdo?$ڕdӷc*~*߃ؾ-f-|r0-eɷ{jWwwmXN{>j]-5s:W]kE[>qQھ~܂в[@ۘcrZZ̮+Tn\/o C%K
endstream
endobj
26 0 obj
<<
/Length 876
/Filter /FlateDecode
>>
stream
HVInI+Ґ
|ɿjɐق\nnlvq{ݻ,;h&͉#:9V`7қA:a#q- ؇vg.R44(i%؉z@ưȂ ~%Lח ;㛅nM-_cx@Bg4-iRZ2de`eiʃXzZsq`qN Øfj
S5!>*i+NKX.?\
3CPGB
AΤ v< kg粍Bv(oxdjRg<̱WVzzȟ|BauBa給4&Yxs;UIqϋ6cCEp_uI&i%k҆_ڪbCa6.CP
q7/fc`.pX0H Պpt;dgƔj(